The size said up to 75 million on their filing last week. The release today still leaves it up in the air as far as to when and with whom they might do an offering. However, the recent insider buying at $1.67 to $1.75 would lead me to believe that the leadership team feels that the current prices are cheaper than what the future price will be.
ACAD did a public offering and went up 10% the day of the offering. ACAD stock triple since the offering in less than 6 months. For me this is a good sign going up which is rare during an offering. Under$2 is not bad also for the future with this company and also with Merck interesting to partner with them.We could see a run over $3-$5 and wait for more data to continue with the upside.